Advisors Asset Management Inc. Sells 1,212 Shares of Natera, Inc. (NASDAQ:NTRA)

Advisors Asset Management Inc. lessened its holdings in Natera, Inc. (NASDAQ:NTRAGet Rating) by 6.6% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 17,035 shares of the medical research company’s stock after selling 1,212 shares during the period. Advisors Asset Management Inc.’s holdings in Natera were worth $604,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Banque Pictet & Cie SA raised its stake in Natera by 8.6% during the 2nd quarter. Banque Pictet & Cie SA now owns 210,510 shares of the medical research company’s stock worth $7,460,000 after acquiring an additional 16,649 shares during the period. Connor Clark & Lunn Investment Management Ltd. raised its stake in Natera by 42.8% during the 2nd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 81,192 shares of the medical research company’s stock worth $2,877,000 after acquiring an additional 24,352 shares during the period. State of New Jersey Common Pension Fund D raised its stake in Natera by 21.7% during the 2nd quarter. State of New Jersey Common Pension Fund D now owns 66,097 shares of the medical research company’s stock worth $2,342,000 after acquiring an additional 11,774 shares during the period. EFG Asset Management North America Corp. raised its stake in Natera by 52.7% during the 2nd quarter. EFG Asset Management North America Corp. now owns 121,059 shares of the medical research company’s stock worth $4,288,000 after acquiring an additional 41,795 shares during the period. Finally, Van ECK Associates Corp raised its stake in Natera by 0.8% during the 2nd quarter. Van ECK Associates Corp now owns 114,216 shares of the medical research company’s stock worth $4,048,000 after acquiring an additional 962 shares during the period. Institutional investors own 92.95% of the company’s stock.

Natera Trading Down 0.6 %

NTRA stock opened at $35.62 on Friday. The firm has a fifty day moving average price of $43.91 and a 200 day moving average price of $42.78. Natera, Inc. has a fifty-two week low of $26.10 and a fifty-two week high of $107.48. The company has a debt-to-equity ratio of 0.78, a quick ratio of 2.95 and a current ratio of 3.10. The firm has a market cap of $3.48 billion, a PE ratio of -6.27 and a beta of 1.33.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on NTRA shares. BTIG Research decreased their target price on shares of Natera from $95.00 to $75.00 in a research note on Wednesday, November 9th. Piper Sandler raised their target price on shares of Natera from $60.00 to $70.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 17th. JPMorgan Chase & Co. lifted their price objective on shares of Natera from $80.00 to $100.00 in a research report on Friday, August 5th. Stephens reduced their price objective on shares of Natera to $67.00 in a research report on Wednesday. Finally, StockNews.com initiated coverage on shares of Natera in a research report on Wednesday, October 12th. They set a “sell” rating on the stock. One equities research analyst has rated the stock with a sell rating and six have issued a buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $83.82.

Insider Activity at Natera

In related news, CEO Steven Leonard Chapman sold 1,674 shares of the firm’s stock in a transaction on Friday, September 23rd. The shares were sold at an average price of $45.30, for a total value of $75,832.20. Following the completion of the transaction, the chief executive officer now directly owns 68,313 shares of the company’s stock, valued at $3,094,578.90. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In related news, CEO Steven Leonard Chapman sold 1,674 shares of the firm’s stock in a transaction on Friday, September 23rd. The shares were sold at an average price of $45.30, for a total value of $75,832.20. Following the completion of the transaction, the chief executive officer now directly owns 68,313 shares of the company’s stock, valued at $3,094,578.90. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, COO Robert Alan Schueren sold 3,135 shares of the firm’s stock in a transaction on Monday, October 24th. The shares were sold at an average price of $42.41, for a total transaction of $132,955.35. Following the completion of the transaction, the chief operating officer now directly owns 4,932 shares of the company’s stock, valued at $209,166.12. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 18,359 shares of company stock valued at $797,832. 10.27% of the stock is owned by corporate insiders.

About Natera

(Get Rating)

Natera, Inc, a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to identify chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle.

Featured Articles

Want to see what other hedge funds are holding NTRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Natera, Inc. (NASDAQ:NTRAGet Rating).

Institutional Ownership by Quarter for Natera (NASDAQ:NTRA)

Receive News & Ratings for Natera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natera and related companies with MarketBeat.com's FREE daily email newsletter.